News & Updates

Show Multimedia Only
Zuranolone safe, effective for postpartum depression

Zuranolone safe, effective for postpartum depression

20 Sep 2023

Use of zuranolone significantly improves depressive symptoms, with no serious side effects, in women with severe postpartum depression (PPD), a common perinatal complication with adverse maternal and infant outcomes, results of a phase III trial have shown.

20 Sep 2023
Extended anticoagulation benefits cancer patients with distal DVT

Extended anticoagulation benefits cancer patients with distal DVT

20 Sep 2023 byAudrey Abella

In cancer patients with isolated distal deep vein thrombosis (IDDVT), a 12-month anticoagulation regimen with the oral factor Xa inhibitor edoxaban fared better than a 3-month regimen, findings from the ONCO DVT study have shown.

20 Sep 2023
Bimekizumab safe, effective in moderate-to-severe plaque psoriasis

Bimekizumab safe, effective in moderate-to-severe plaque psoriasis

18 Sep 2023 byStephen Padilla

The high clinical response levels achieved with bimekizumab over 48 weeks persist up to week 96 in patients with moderate-to-severe plaque psoriasis, results of the BE RADIANT phase IIIb trial have shown. In addition, those on secukinumab who switched to bimekizumab have achieved similar responses at 96 weeks.

18 Sep 2023